Lantern Pharma Cash Flow Statement 2019-2024 | LTRN

Fifteen years of historical annual cash flow statements for Lantern Pharma (LTRN).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-15.96$-14.26$-12.36$-5.91$-2.43
$-0.16$0.09$0.15$0.00$0.00
$1.24$2.01$1.02$1.19$0.12
$1.08$2.10$1.17$1.20$0.12
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$0.77$-1.19$-1.02$-1.06$-0.19
$0.54$-0.61$0.60$-0.94$0.18
$-14.35$-12.77$-10.59$-5.65$-2.13
$-0.02$-0.03$-0.02$-0.02$-0.01
$0$0$0$0$0
$0$0$0$0$0
$-0.91$0.21$-19.52$0$0
$0$0$0$0$0
$-0.91$0.21$-19.52$0$0
$0$0$0$0$0
$-0.93$0.18$-19.53$-0.02$-0.01
$0$0$0$0.11$0
$0$0$0$0$0
$0$0$0$0.11$0
$-0.50$-2.18$68.20$26.30$2.92
$-0.50$-2.18$68.20$26.30$2.92
$0$0$0$0$0
$0$0$-4.78$-2.75$0
$-0.50$-2.18$63.42$23.67$2.92
$-15.81$-14.78$33.30$18.00$0.79
$1.07$1.19$0.96$1.19$0.12
$0$0$0$0$0